Mesoblast Limited (ASX:MSB)

Mesoblast Revenue

Mesoblast had revenue of $25.67M USD in the half year ending December 31, 2025, with 1,526.81% growth. This brings the company's revenue in the last twelve months to $65.38M, up 1,053.16% year-over-year. In the fiscal year ending June 30, 2025, Mesoblast had annual revenue of $17.20M with 191.39% growth.

• Revenue (ttm): $65.38M
• Revenue Growth: +1,053.16%
• P/S Ratio: 27.52
• Revenue / Employee: $807.21K
• Employees: 81
• Market Cap: 2.70B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	17.20M	11.30M	191.39%
Jun 30, 2024	5.90M	-1.60M	-21.32%
Jun 30, 2023	7.50M	-2.71M	-26.54%
Jun 30, 2022	10.21M	2.78M	37.36%
Jun 30, 2021	7.43M	-24.72M	-76.88%
Jun 30, 2020	32.16M	15.43M	92.30%
Jun 30, 2019	16.72M	-619.00K	-3.57%
Jun 30, 2018	17.34M	14.93M	618.95%
Jun 30, 2017	2.41M	-40.14M	-94.33%
Jun 30, 2016	42.55M	22.79M	115.31%
Jun 30, 2015	19.76M	-	-
Jun 30, 2014	-	-	-
Jun 30, 2013	-	-	-
Jun 30, 2012	-	-	-